MEI Pharma Performance
| MEIPDelisted Stock | USD 3.07 0.18 6.23% |
The company secures a Beta (Market Risk) of 0.21, which conveys not very significant fluctuations relative to the market. As returns on the market increase, MEI Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding MEI Pharma is expected to be smaller as well. MEI Pharma now secures a risk of 0.0%. Please verify MEI Pharma downside variance, and the relationship between the sortino ratio and accumulation distribution , to decide if MEI Pharma will be following its current price movements.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days MEI Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward indicators, MEI Pharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 16.9 M | |
| Total Cashflows From Investing Activities | 49.1 M | |
| Free Cash Flow | -50.5 M |
MEI |
MEI Pharma Relative Risk vs. Return Landscape
If you would invest 307.00 in MEI Pharma on November 7, 2025 and sell it today you would earn a total of 0.00 from holding MEI Pharma or generate 0.0% return on investment over 90 days. MEI Pharma is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than MEI, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
MEI Pharma Target Price Odds to finish over Current Price
The tendency of MEI Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 3.07 | 90 days | 3.07 | about 74.0 |
Based on a normal probability distribution, the odds of MEI Pharma to move above the current price in 90 days from now is about 74.0 (This MEI Pharma probability density function shows the probability of MEI Stock to fall within a particular range of prices over 90 days) .
MEI Pharma Price Density |
| Price |
Predictive Modules for MEI Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MEI Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.MEI Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. MEI Pharma is not an exception. The market had few large corrections towards the MEI Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold MEI Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of MEI Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.85 | |
β | Beta against Dow Jones | 0.21 | |
σ | Overall volatility | 1.43 | |
Ir | Information ratio | 0.1 |
MEI Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MEI Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MEI Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| MEI Pharma is now traded under the symbol LITS. Please update your portfolios or report it if you believe this is an error. Report It! | |
| MEI Pharma is not yet fully synchronised with the market data | |
| MEI Pharma has a very high chance of going through financial distress in the upcoming years | |
| MEI Pharma currently holds about 153.25 M in cash with (50.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.15. |
MEI Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of MEI Stock often depends not only on the future outlook of the current and potential MEI Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MEI Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.7 M | |
| Dividends Paid | -11.7 M | |
| Cash And Short Term Investments | 38.3 M |
MEI Pharma Fundamentals Growth
MEI Stock prices reflect investors' perceptions of the future prospects and financial health of MEI Pharma, and MEI Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MEI Stock performance.
| Return On Equity | -0.9 | |||
| Return On Asset | -0.23 | |||
| Current Valuation | 59.84 M | |||
| Shares Outstanding | 32.84 M | |||
| Price To Earning | 30.29 X | |||
| Price To Book | 5.02 X | |||
| Price To Sales | 0.27 X | |||
| Revenue | 65.3 M | |||
| EBITDA | 18.16 M | |||
| Cash And Equivalents | 153.25 M | |||
| Cash Per Share | 1.15 X | |||
| Total Debt | 8.36 M | |||
| Debt To Equity | 0.18 % | |||
| Book Value Per Share | 2.93 X | |||
| Cash Flow From Operations | (50.47 M) | |||
| Earnings Per Share | (4.75) X | |||
| Total Asset | 41.38 M | |||
| Retained Earnings | (388.22 M) | |||
| Current Asset | 46.75 M | |||
| Current Liabilities | 5.51 M | |||
About MEI Pharma Performance
Assessing MEI Pharma's fundamental ratios provides investors with valuable insights into MEI Pharma's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the MEI Pharma is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California. Mei Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 102 people.Things to note about MEI Pharma performance evaluation
Checking the ongoing alerts about MEI Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MEI Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MEI Pharma is now traded under the symbol LITS. Please update your portfolios or report it if you believe this is an error. Report It! | |
| MEI Pharma is not yet fully synchronised with the market data | |
| MEI Pharma has a very high chance of going through financial distress in the upcoming years | |
| MEI Pharma currently holds about 153.25 M in cash with (50.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.15. |
- Analyzing MEI Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MEI Pharma's stock is overvalued or undervalued compared to its peers.
- Examining MEI Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MEI Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MEI Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MEI Pharma's stock. These opinions can provide insight into MEI Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in MEI Stock
If you are still planning to invest in MEI Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MEI Pharma's history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |